id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-315632-29x6l5yh	Rali, Aniket S	High-flow Nasal Cannula Oxygenation Revisited in COVID-19	2020-04-21		.txt	text/plain	1098	60	48	A case series of 138 COVID-19 patients from Wuhan, China showed that a total of 36 (26%) patients required ICU level care, of whom 22 (61%) developed ARDS and 17 (47.2%) required invasive mechanical ventilation. 1 Other retrospective analyses have reported similarly that 20-31% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients develop ARDS and require ICU care. [2] [3] [4] Therefore, it is critical that we explore the utility and safety of other forms of respiratory support devices, including high-flow nasal cannula oxygenation (HFNCO) in the treatment of acute respiratory failure. 4 We present a case of a SARS-CoV-2-positive patient with acute respiratory failure who was successfully treated with HFNCO. On day 3, his hypoxic respiratory failure worsened, requiring high-flow nasal cannula at 40 l/min and 90% fractional inspired oxygen, (FiO 2 ) and he was transferred to the medical ICU. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study	./cache/cord-315632-29x6l5yh.txt	./txt/cord-315632-29x6l5yh.txt